Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Revenue 2011-2024 | ZTS

Zoetis annual/quarterly revenue history and growth rate from 2011 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Zoetis revenue for the quarter ending December 31, 2024 was $2.317B, a 4.7% increase year-over-year.
  • Zoetis revenue for the twelve months ending December 31, 2024 was $9.256B, a 8.33% increase year-over-year.
  • Zoetis annual revenue for 2024 was $9.256B, a 8.33% increase from 2023.
  • Zoetis annual revenue for 2023 was $8.544B, a 5.74% increase from 2022.
  • Zoetis annual revenue for 2022 was $8.08B, a 3.91% increase from 2021.
  
Zoetis Annual Revenue
(Millions of US $)
2024 $9,256
2023 $8,544
2022 $8,080
2021 $7,776
2020 $6,675
2019 $6,260
2018 $5,825
2017 $5,307
2016 $4,888
2015 $4,765
2014 $4,785
2013 $4,561
2012 $4,336
2011 $4,233
2010 $3,582
Zoetis Quarterly Revenue
(Millions of US $)
2024-12-31 $2,317
2024-09-30 $2,388
2024-06-30 $2,361
2024-03-31 $2,190
2023-12-31 $2,213
2023-09-30 $2,151
2023-06-30 $2,180
2023-03-31 $2,000
2022-12-31 $2,040
2022-09-30 $2,002
2022-06-30 $2,052
2022-03-31 $1,986
2021-12-31 $1,967
2021-09-30 $1,990
2021-06-30 $1,948
2021-03-31 $1,871
2020-12-31 $1,807
2020-09-30 $1,786
2020-06-30 $1,548
2020-03-31 $1,534
2019-12-31 $1,674
2019-09-30 $1,584
2019-06-30 $1,547
2019-03-31 $1,455
2018-12-31 $1,564
2018-09-30 $1,480
2018-06-30 $1,415
2018-03-31 $1,366
2017-12-31 $1,460
2017-09-30 $1,347
2017-06-30 $1,269
2017-03-31 $1,231
2016-12-31 $1,277
2016-09-30 $1,241
2016-06-30 $1,208
2016-03-31 $1,162
2015-12-31 $1,274
2015-09-30 $1,214
2015-06-30 $1,175
2015-03-31 $1,102
2014-12-31 $1,320
2014-09-30 $1,210
2014-06-30 $1,158
2014-03-31 $1,097
2013-12-31 $1,254
2013-09-30 $1,103
2013-06-30 $1,114
2013-03-31 $1,090
2012-12-31 $1,176
2012-09-30 $1,019
2012-06-30 $1,094
2012-03-31 $1,047
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $70.536B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.932B 30.75
Daiichi Sankyo, - (DSNKY) $45.590B 27.78
Takeda Pharmaceutical (TAK) Japan $43.083B 9.54
Sandoz Group AG (SDZNY) Switzerland $21.859B 0.00
Merck (MKKGY) Germany $18.359B 16.44
Astellas Pharma (ALPMY) Japan $17.680B 12.53
United Therapeutics (UTHR) United States $16.544B 16.27
Summit Therapeutics (SMMT) United States $15.759B 0.00
Shionogi (SGIOY) Japan $12.012B 12.03
Neurocrine Biosciences (NBIX) United States $11.468B 34.96
Corcept Therapeutics (CORT) United States $7.619B 57.71
Orion OYJ (ORINY) Finland $7.614B 21.41
Madrigal Pharmaceuticals (MDGL) United States $7.354B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $5.918B 38.31
Grifols, S.A (GRFS) Spain $5.033B 0.00
Ionis Pharmaceuticals (IONS) United States $4.901B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.114B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.265B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.775B 12.58
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.395B 14.31
Centessa Pharmaceuticals (CNTA) United Kingdom $2.251B 0.00
Hypermarcas (HYPMY) Brazil $2.179B 0.00
Soleno Therapeutics (SLNO) United States $2.120B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.875B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.839B 0.00
Evotec AG (EVO) Germany $1.623B 0.00
Dyne Therapeutics (DYN) United States $1.416B 0.00
Ardelyx (ARDX) United States $1.371B 0.00
Indivior (INDV) United States $1.355B 5.52
Guardian Pharmacy Services (GRDN) United States $1.250B 0.00
ARS Pharmaceuticals (SPRY) United States $1.168B 0.00
Ocular Therapeutix (OCUL) United States $1.145B 0.00
Xencor (XNCR) United States $1.141B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.115B 0.00
Harrow (HROW) United States $1.083B 0.00
Enliven Therapeutics (ELVN) United States $1.059B 0.00
Collegium Pharmaceutical (COLL) United States $0.957B 5.22
Bioventus (BVS) United States $0.845B 26.69
Avadel Pharmaceuticals (AVDL) Ireland $0.830B 0.00
Cronos Group (CRON) Canada $0.754B 0.00
Verve Therapeutics (VERV) United States $0.726B 0.00
Relay Therapeutics (RLAY) United States $0.670B 0.00
USANA Health Sciences (USNA) United States $0.604B 11.20
Elite Pharmaceuticals (ELTP) United States $0.566B 0.00
OmniAb (OABI) United States $0.538B 0.00
Xeris Biopharma Holdings (XERS) United States $0.535B 0.00
Savara (SVRA) United States $0.484B 0.00
KalVista Pharmaceuticals (KALV) United States $0.482B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.473B 0.00
ProKidney (PROK) United States $0.470B 0.00
Organogenesis (ORGO) United States $0.465B 0.00
Akebia Therapeutics (AKBA) United States $0.465B 0.00
Altimmune (ALT) United States $0.453B 0.00
Siga Technologies (SIGA) United States $0.438B 5.12
Zevra Therapeutics (ZVRA) United States $0.431B 0.00
Oruka Therapeutics (ORKA) United States $0.391B 0.00
Aldeyra Therapeutics (ALDX) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 154.07
Esperion Therapeutics (ESPR) United States $0.366B 0.00
Tourmaline Bio (TRML) United States $0.355B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.307B 0.00
Aquestive Therapeutics (AQST) United States $0.303B 0.00
Korro Bio (KRRO) United States $0.281B 0.00
Avita Medical (RCEL) United States $0.277B 0.00
Heron Therapeutics (HRTX) United States $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 15.94
CytoDyn (CYDY) United States $0.267B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.255B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
4D Molecular Therapeutics (FDMT) United States $0.226B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Nanobiotix S.A (NBTX) France $0.190B 0.00
Nektar Therapeutics (NKTR) United States $0.181B 0.00
Lyell Immunopharma (LYEL) United States $0.178B 0.00
VAXART, INC (VXRT) United States $0.170B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.169B 0.00
Acrivon Therapeutics (ACRV) United States $0.169B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Inhibikase Therapeutics (IKT) United States $0.163B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.152B 0.00
Lexeo Therapeutics (LXEO) United States $0.149B 0.00
Silence Therapeutics (SLN) United Kingdom $0.145B 0.00
Telomir Pharmaceuticals (TELO) United States $0.128B 0.00
Inotiv (NOTV) United States $0.127B 0.00
Achieve Life Sciences (ACHV) Canada $0.118B 0.00
Cassava Sciences (SAVA) United States $0.116B 0.00
ElectroCore (ECOR) United States $0.116B 0.00
Journey Medical (DERM) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Metagenomi (MGX) United States $0.098B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Protara Therapeutics (TARA) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Assertio Holdings (ASRT) United States $0.080B 21.04
Regulus Therapeutics (RGLS) United States $0.079B 0.00
Nutriband (NTRB) United States $0.079B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Karyopharm Therapeutics (KPTI) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Avalo Therapeutics (AVTX) United States $0.076B 0.00
Fractyl Health (GUTS) United States $0.076B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Mural Oncology (MURA) Ireland $0.073B 0.00
Gain Therapeutics (GANX) United States $0.072B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
AleAnna (ANNA) United States $0.068B 0.00
Century Therapeutics (IPSC) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
FibroGen (FGEN) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Iterum Therapeutics (ITRM) Ireland $0.053B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
AlloVir (ALVR) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
CASI Pharmaceuticals (CASI) China $0.039B 0.00
Surrozen (SRZN) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
BioVie (BIVI) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Traws Pharma (TRAW) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
Lipocine (LPCN) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Biomerica (BMRA) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Mangoceuticals (MGRX) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
ProPhase Labs (PRPH) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
CERo Therapeutics Holdings (CERO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00